COLFAX CORP (CFX) Stock Price & Overview

NYSE:CFX

Current stock price

39.06
-1.53 (-3.77%)
At close:
39.06
0 (0%)
After Hours:

The current stock price of CFX is 39.06 null. Today CFX is down by -3.77%. In the past month the price increased by 7.54%. In the past year, price decreased by -10.02%.

CFX Key Statistics

52-Week Range35.66 - 54.67
Current CFX stock price positioned within its 52-week range.
1-Month Range35.66 - 41.105
Current CFX stock price positioned within its 1-month range.
Market Cap
6.103B
P/E
18.34
Fwd P/E
5.37
EPS (TTM)
2.13
Dividend Yield
N/A

CFX Stock Performance

Today
-3.77%
1 Week
-1.04%
1 Month
+7.54%
3 Months
-12.81%
Longer-term
6 Months -19.41%
1 Year -10.02%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

CFX Stock Chart

COLFAX CORP / CFX Daily stock chart

CFX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CFX. When comparing the yearly performance of all stocks, CFX is a bad performer in the overall market: 61.5% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CFX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CFX. Both the profitability and financial health of CFX have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CFX Earnings

Next Earnings DateApr 28, 2022
Last Earnings DateFeb 22, 2022
PeriodQ4 / 2021
EPS Reported$0.59
Revenue Reported
EPS Surprise 1.86%
Revenue Surprise 0.13%

CFX Forecast & Estimates

19 analysts have analysed CFX and the average price target is 51.43 null. This implies a price increase of 31.66% is expected in the next year compared to the current price of 39.06.

For the next year, analysts expect an EPS growth of 241.51% and a revenue growth 7.2% for CFX


Analysts
Analysts78.95
Price Target51.43 (31.67%)
EPS Next Y241.51%
Revenue Next Year7.2%

CFX Groups

Sector & Classification

CFX Financial Highlights

Over the last trailing twelve months CFX reported a non-GAAP Earnings per Share(EPS) of 2.13. The EPS increased by 53.24% compared to the year before.


Income Statements
Revenue(TTM)3.85B
Net Income(TTM)71.68M
Industry RankSector Rank
PM (TTM) 1.86%
ROA 0.84%
ROE 1.55%
Debt/Equity 0.45
Chartmill High Growth Momentum
EPS Q2Q%15.69%
Sales Q2Q%23.57%
EPS 1Y (TTM)53.24%
Revenue 1Y (TTM)25.51%

CFX Ownership

Ownership
Inst Owners0%
Shares156.25M
Float142.06M
Ins Owners1.27%
Short Float %N/A
Short RatioN/A

About CFX

Company Profile

CFX logo image Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.

Company Info

IPO: 2008-05-08

COLFAX CORP

2711 Centerville Road, Suite 400

Wilmington DELAWARE 20701 US

CEO: Matthew L. Trerotola

Employees: 16200

CFX Company Website

Phone: 13022529160.0

COLFAX CORP / CFX FAQ

Can you describe the business of COLFAX CORP?

Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.


What is the current price of CFX stock?

The current stock price of CFX is 39.06 null. The price decreased by -3.77% in the last trading session.


What is the dividend status of COLFAX CORP?

CFX does not pay a dividend.


What is the ChartMill rating of COLFAX CORP stock?

CFX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Where is COLFAX CORP (CFX) stock traded?

CFX stock is listed on the New York Stock Exchange exchange.


Who owns COLFAX CORP?

You can find the ownership structure of COLFAX CORP (CFX) on the Ownership tab.